Related Experiment Videos
Summary
Cefaclor, an oral cephalosporin antibiotic, demonstrated high efficacy across various infections, including respiratory and skin conditions. This antibiotic showed a low incidence of adverse reactions, making it a promising treatment option.
Area of Science:
- Pharmacology
- Clinical Medicine
- Infectious Diseases
Background:
- Cefaclor is an orally administered, semisynthetic cephalosporin antibiotic.
- The study aimed to evaluate the clinical efficacy and safety of Cefaclor in a large patient cohort.
Purpose of the Study:
- To assess the clinical effectiveness of Cefaclor in treating common bacterial infections.
- To determine the safety profile and incidence of adverse reactions associated with Cefaclor use.
Main Methods:
- A multicenter study involving 62 investigators across six countries.
- 1493 adult and pediatric patients with various infections were enrolled.
- Data on clinical response and adverse events were pooled and analyzed.
Main Results:
- Satisfactory clinical response rates were observed: 80% for urinary tract infections, 87% for upper respiratory tract infections, 90% for otitis media, 99% for lower respiratory tract infections, and 96% for skin infections.
- Low incidence of adverse reactions was reported: 2.6% gastrointestinal and 1.5% hypersensitivity.
- Particularly notable efficacy was seen in otitis media and lower respiratory tract infections.
Conclusions:
- Cefaclor is an effective oral antibiotic for a range of common bacterial infections.
- The antibiotic is well-tolerated, with a low rate of adverse events.
- Cefaclor shows significant promise for treating otitis media and lower respiratory tract infections.